[1] WANG HW, JIAO HM, JIANG ZR, et al. Propofol inhibits migration and induces apoptosis of pancreatic cancer PANC-1 cells through miR-34a-mediated E-cadherin and LOC285194 signals[J]. Bioengineered, 2020, 11(1): 510. doi: 10.1080/21655979.2020.1754038
[2] VON HOFF DD, ERVIN T, ARENA FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine[J]. N Engl J Med, 2013, 369(18): 1691. doi: 10.1056/NEJMoa1304369
[3] ABREU FB, LIU XY, TSONGALIS GJ. miRNA analysis in pancreatic cancer: the Dartmouth experience[J]. Clin Chem Lab Med, 2017, 55(5): 755.
[4] JIANG Q, CHENG L, MA DY, et al. FBXL19-AS1 exerts oncogenic function by sponging miR-431-5p to regulate RAF1 expression in lung cancer[J]. Biosci Rep, 2019, 39(1): 1.
[5] SU WB, LIU ZY. MiR-431 inhibits colorectal cancer cell invasion via repressing CUL4B[J]. Eur Rev Med Pharmacol Sci, 2018, 22(10): 3047.
[6] LIU Y, LI L, LIU Z, et al. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma[J]. Cancer Biomark, 2018, 22(4): 727. doi: 10.3233/CBM-181253
[7] XU RL, HE W, TANG J, et al. Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression[J]. Exp Cell Res, 2018, 363(2): 310. doi: 10.1016/j.yexcr.2018.01.026
[8] WU XF. Expressions of miR-21 and miR-210 in breast cancer and their predictive values for prognosis[J]. Iran J Public Health, 2020, 49(1): 21.
[9] CHEN YS, LU Y, REN YL, et al. Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma[J]. Theranostics, 2020, 10(11): 4983. doi: 10.7150/thno.43046
[10] LI J, LIN TY, CHEN L, et al. miR-19 regulates the expression of interferon-induced genes and MHC class Ⅰ genes in human cancer cells[J]. Int J Med Sci, 2020, 17(7): 953. doi: 10.7150/ijms.44377
[11] KONG Q, HAN J, DENG H, et al. miR-431-5p alters the epithelial-to-mesenchymal transition markers by targeting UROC28 in hepatoma cells[J]. Onco Targets Ther, 2018, 11(3): 6489.
[12] LI S, SUN Z, CHEN T, et al. The role of miR-431-5p in regulating pulmonary surfactant expression in vitro[J]. Cell Mol Biol Lett, 2019, 24(2): 25.
[13] DU YM, WANG YB. MiR-637 inhibits proliferation and invasion of hepatoma cells by targeted degradation of AKT1[J]. Eur Rev Med Pharmacol Sci, 2019, 23(2): 567.
[14] YAO J, ZHANG P, LI J, et al. MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1[J]. Oncol Lett, 2017, 14(1): 1097. doi: 10.3892/ol.2017.6200
[15] WANG C, LIU H, QIU Q, et al. TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1[J]. Oncogenesis, 2017, 6(4): e323. doi: 10.1038/oncsis.2017.18
[16] SI L, XU L, YIN L, et al. Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway[J]. Br J Pharmacol, 2017, 174(7): 553. doi: 10.1111/bph.13718
[17] ZHANG G, CHEN HX, YANG SN, et al. MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA[J]. Eur Rev Med Pharmacol Sci, 2020, 24(2): 691.